Otsu, Japan

Kunio Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunio Watanabe. Retrieved from https://idiyas.com/inventor/kunio-watanabe-wcjyq7u1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunio Watanabe: Innovator in Polypeptide Research

Introduction

Kunio Watanabe is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides with ACTH-like activities. His work has implications for various medical applications, showcasing the importance of innovation in this area.

Latest Patents

Watanabe holds a patent for a polypeptide of the formula that exhibits ACTH-like activities. This invention is crucial for advancing research in hormonal treatments and understanding the mechanisms of action in related therapies. He has 1 patent to his name, reflecting his focused contributions to the scientific community.

Career Highlights

Throughout his career, Watanabe has been associated with Shionogi Company Limited, a prominent pharmaceutical company. His role there has allowed him to engage in cutting-edge research and development, further enhancing his expertise in the field of polypeptides.

Collaborations

Watanabe has collaborated with esteemed colleagues such as Masaru Shin and Ken Inouye. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas, which is essential in scientific research.

Conclusion

Kunio Watanabe's work in polypeptide research exemplifies the impact of innovation in the pharmaceutical industry. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…